^
    1year
    Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=66, Recruiting, Shanghai Best-Link Bioscience, LLC | Not yet recruiting --> Recruiting
    Enrollment open
    |
    BL0020
    1year
    Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=66, Not yet recruiting, Shanghai Best-Link Bioscience, LLC | Initiation date: Jul 2023 --> Oct 2023
    Trial initiation date • Metastases
    |
    BL0020
    over1year
    Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=66, Not yet recruiting, Shanghai Best-Link Bioscience, LLC
    New P1 trial • Metastases
    |
    BL0020